Skip Nav Destination
Letter to Blood|
October 5, 2023
Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells
Clinical Trials & Observations
Philipp Karschnia,
Philipp Karschnia
1Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
2Section for Neuro-Oncology, Department of Neurosurgery, Ludwig Maximilian University, Munich, Germany
3German Cancer Consortium, Partner Site Munich, Germany
Search for other works by this author on:
Kevin C. Miller,
Kevin C. Miller
4Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
Search for other works by this author on:
Andrew J. Yee,
Andrew J. Yee
4Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
Search for other works by this author on:
Kai Rejeski,
Kai Rejeski
5Department of Medicine III, Section for Cellular Immunotherapy, Ludwig Maximilian University, Munich, Germany
Search for other works by this author on:
P. Connor Johnson,
P. Connor Johnson
4Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
Search for other works by this author on:
Noopur Raje,
Noopur Raje
4Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
Search for other works by this author on:
Matthew J. Frigault,
Matthew J. Frigault
6Cellular Immunotherapy Program, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
Search for other works by this author on:
Jorg Dietrich
Jorg Dietrich
1Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
Search for other works by this author on:
Blood (2023) 142 (14): 1243–1248.
Article history
Submitted:
March 22, 2023
Accepted:
July 2, 2023
First Edition:
July 20, 2023
Connected Content
A commentary has been published:
BCMA-CAR T-cell treatment–associated parkinsonism
Citation
Philipp Karschnia, Kevin C. Miller, Andrew J. Yee, Kai Rejeski, P. Connor Johnson, Noopur Raje, Matthew J. Frigault, Jorg Dietrich; Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells. Blood 2023; 142 (14): 1243–1248. doi: https://doi.org/10.1182/blood.2023020571
Download citation file:
My Account
Sign In
October 5 2023
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal